ASB-8, or Ankyrin Repeat and SOCS Box Containing 8, is a gene that encodes a protein belonging to the ASB family, part of the larger SOCS (Suppressor of Cytokine Signaling) box protein family. This family is characterized by the presence of ankyrin repeats and a SOCS box, both of which are important for the protein's function.The ankyrin repeat is a common protein motif involved in protein-protein interactions. In ASB-8, these repeats likely facilitate binding to various target proteins. The SOCS box, on the other hand, is involved in mediating the degradation of proteins. It typically recruits components of the ubiquitin-proteasome system, a cellular mechanism that tags unwanted or damaged proteins with ubiquitin to signal their degradation in the proteasome.
ASB-8 is involved in the ubiquitination process, where it likely functions as a part of an E3 ubiquitin ligase complex. E3 ubiquitin ligases are responsible for the transfer of ubiquitin from an E2 ubiquitin-conjugating enzyme to specific substrate proteins, marking them for degradation. This process is crucial for regulating protein levels and activity in the cell, impacting various cellular processes and pathways.The specific roles and targets of ASB-8 in cells are not fully understood. However, proteins in the ASB family have been implicated in a range of cellular functions, including signal transduction, immune responses, and cellular homeostasis. Given its role in protein ubiquitination, ASB-8 is likely involved in these processes by regulating the degradation of key proteins.ASB-8's involvement in ubiquitination also suggests its relevance in diseases where protein degradation is disrupted, such as neurodegenerative diseases, cancer, and inflammatory disorders. Understanding the function of ASB-8 can therefore contribute to insights into these conditions.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lactacystin | 133343-34-7 | sc-3575 sc-3575A | 200 µg 1 mg | $188.00 $575.00 | 60 | |
Another proteasome inhibitor, could impact protein ubiquitination processes, potentially affecting ASB-8. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
A specific proteasome inhibitor used in cancer therapy, may indirectly affect ASB-8 function. | ||||||
Thalidomide | 50-35-1 | sc-201445 sc-201445A | 100 mg 500 mg | $111.00 $357.00 | 8 | |
Modulates protein degradation pathways, could indirectly influence ASB-8 activity. | ||||||
Lenalidomide | 191732-72-6 | sc-218656 sc-218656A sc-218656B | 10 mg 100 mg 1 g | $50.00 $374.00 $2071.00 | 18 | |
An analog of thalidomide, affects protein degradation, potentially impacting ASB-8 activity. | ||||||
Pomalidomide | 19171-19-8 | sc-364593 sc-364593A sc-364593B sc-364593C sc-364593D sc-364593E | 5 mg 10 mg 50 mg 100 mg 500 mg 1 g | $100.00 $143.00 $312.00 $468.00 $1248.00 $1997.00 | 1 | |
Another thalidomide analog, influences protein ubiquitination and degradation, potentially affecting ASB-8. | ||||||